Cagkan Sayin/Adobe Stock

The Centers for Medicare & Medicaid Services has issued revised guidance for implementation of the new Medicare Drug Price Negotiation Program, perhaps in response to the four lawsuits challenging the program. The first round of negotiations will occur in 2023 and 2024, resulting in prices that will be effective beginning in 2026.

Continue Reading for Free

Register and gain access to:

  • Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
  • Educational webcasts, white papers, and ebooks from industry thought leaders
  • Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

Consumer Driven Health Care
Core and Group Health
Health Care Reform
Employer-Paid